Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Leesol’s fundamental product, Blissol, is to promote wellness technology
08 October 2025

Leesol’s fundamental product, Blissol, is to promote wellness technology

Image Credit: Amazon Announcement  The leesol, a leading innovative South Korean wellness technology company, proudly confirmed its key product’s Blissol Kickstarter campaign. The successful campaign of Blissol has fuelled Indiegogo Indemand momentum, and its most talked-about smart p...

Smith+Nephew’s scientific data proves suitable for pressure injury prevention
08 October 2025

Smith+Nephew’s scientific data proves suitable for pressure injury prevention

Image Credit: Medical Device Network Announcement  Smith+Nephew, the leading medical technology business, is proud to introduce its new data created by Professor Amit Gefen and his research team, specifically mentioned on the public ground, with its publication in the International Wound Jo...

Center of discussion ‘cell and gene therapy’
08 October 2025

Center of discussion ‘cell and gene therapy’

Image Credit: CSL Announcement  As the annual event in Phoenix witnessed, industry leaders discussed that cell and gene therapy remained a constant breath in a state of flux, along with regulatory contributions and M&A activity, indicating momentum. At the same time, marketization chall...

Arrowhead’s digital procurement platform in Nigeria
07 October 2025

Arrowhead’s digital procurement platform in Nigeria

Image Credit: Techcabal Announcement  Arrowhead Pharmaceuticals has introduced a new digital procurement platform for its Nigerian health market. Also, its efforts to enhance medicine supply chains as an excellent initiative to deal with systemic inefficiencies impacting pharmacies and hosp...

American healthcare MNC boost to India’s primary healthcare centres
07 October 2025

American healthcare MNC boost to India’s primary healthcare centres

Image Credit: StudyIQ Announcement The American leading multinational healthcare company, Abbott, in partnership with Americares India Foundation, has completed its level-up initiative of 216 primary health centres (PHCs) to health and wellness centres throughout the 12 states of India from the ...

Cleveland and Genialis’s clinical collaboration
07 October 2025

Cleveland and Genialis’s clinical collaboration

Image Credit: Cleveland Announcement The genialis, a leading RNA biomarker company, has entered a clinical partnership with the Cleveland Clinic, one of the leading academic medical centers, to establish AI-powered tools that will help doctors address the prominent treatment options for pancreat...

Bial, in excellence race with its ongoing clinical trial
07 October 2025

Bial, in excellence race with its ongoing clinical trial

Image Credit: Bial Announcement  Bial, a leading innovation-centric biopharmaceutical company targeting rare diseases and neurosciences, proudly mentioned its key progress in its current ACTIVATE (NCT05819359), phase 2 clinical trial examining the tolerability, efficacy, safety, pharmacokin...

Hackensack and Spotiearly partnered to utilize AI and more in early cancer detection
06 October 2025

Hackensack and Spotiearly partnered to utilize AI and more in early cancer detection

Image Credit: Fierce Healthcare Announcement  Hackensack Meridian Health, a non-profit healthcare US-based organization, has entered a partnership with SpotiEarly for detecting early cancer with the help of trained dogs and AI potential. The dogs are capable of addressing fluctuation in odo...

Alpha Cognition’s proposed shares to the investors
06 October 2025

Alpha Cognition’s proposed shares to the investors

Announcement  Alpha Cognition Inc., a known marketed stage biopharmaceutical company committed to discovering innovative treatments for neurodegenerative diseases, confirmed its proposed offering and sale of common shares to a few investors, and pre-funded warrants to buy its common shares i...

OS therapies’ regulatory update in drug development submission procedure
06 October 2025

OS therapies’ regulatory update in drug development submission procedure

Image Credit: Drug Discovery and Development Announcement OS Therapies Inc., a leading antibody drug conjugate and clinical-stage cancer immunotherapy biotechnology company has informed a regulatory update on its further plans for completing its marketing authorizations in the united kingdom (UK...